NCT06918184 Timing of Specific Exercise Therapy After Breast Cancer Surgery: Early Versus Delayed Initiation
| NCT ID | NCT06918184 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Al Hayah University In Cairo |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2025-04-15 |
| Primary Completion | 2026-11-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2025-04-15 with a primary completion date of 2026-11-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This single-center, parallel-group randomized controlled trial (RCT) will compare two timings for initiating specific exercise therapy after breast cancer surgery. The study tests whether early initiation (within the first postoperative week) versus delayed initiation (at 3 weeks postoperative) results in superior upper limb function at 6 months as measured by the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire. Secondary outcomes include pain intensity (Visual Analog Scale, VAS) and wound-related complications such as drainage time and hematoma incidence.
Eligibility Criteria
Inclusion Criteria: * Women aged 18-65 years. * Scheduled to undergo breast cancer surgery with axillary node dissection. * At risk for upper limb morbidity based on preoperative assessment. * Able to provide informed consent and complete study questionnaires. * Willing and able to attend scheduled physiotherapy sessions and follow-up evaluations. Exclusion Criteria: * Diagnosis of recurrent or metastatic breast cancer. * Concurrent participation in another rehabilitation intervention or clinical trial. * Severe comorbidities (e.g., uncontrolled cardiovascular disease, severe orthopedic conditions) that preclude safe participation. * History of previous shoulder surgery or chronic upper extremity musculoskeletal disorders unrelated to breast cancer treatment. * Inability to understand or complete study materials in English. * Pregnancy or lactation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06918184 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06918184 currently recruiting?
Yes, NCT06918184 is actively recruiting participants. Contact the research team at mohamed.elmeligie@ahuc.edu.eg for enrollment information.
Where is the NCT06918184 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06918184 clinical trial?
NCT06918184 is sponsored by Al Hayah University In Cairo. The trial plans to enroll 140 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.